Biocon dips marginally as Syngene plans for IPO

India Infoline News Service | Mumbai | April 23, 2015 16:02 IST

The company's subsidiary - Syngene International filed a Draft Red Herring Prospectus with the Securities and Exchange Board of India for an IPO.

Biocon Limited
Biocon surged over 3% to a high of Rs. 470 after the company's subsidiary - Syngene International filed a Draft Red Herring Prospectus with the Securities and Exchange Board of India for an IPO. 
The stock, however, ended down nearly a percent at Rs. 452 at the BSE counter. 
The stock has hit a high of RS. 470 and a low of Rs. 449.

***Note: This is a NSE Chart

 

Advertisements

  • Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.